pyrrolidine dithiocarbamate has been researched along with Drug Withdrawal Symptoms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rehni, AK; Singh, N | 1 |
| Capasso, A | 1 |
2 other study(ies) available for pyrrolidine dithiocarbamate and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Ammonium pyrrolidine dithiocarbamate and RS 102895 attenuate opioid withdrawal in vivo and in vitro.
Topics: Animals; Benzoxazines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Female; Ileum; Male; Mice; Morphine; Naloxone; NF-kappa B; Piperidines; Pyrrolidines; Rats; Rats, Wistar; Receptors, CCR2; Substance Withdrawal Syndrome; Thiocarbamates | 2012 |
Involvement of nuclear factor-kB in the expression of opiate withdrawal.
Topics: Animals; Antioxidants; Guinea Pigs; Ileum; Male; Morphine; Narcotics; NF-kappa B; Opioid-Related Disorders; Pyrrolidines; Substance Withdrawal Syndrome; Thiocarbamates | 2001 |